Rho Capital Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Rho Capital Partners’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,067,892	Closed	-$57.1M	–	10
2016 Q1	$57.1M	Hold	1,067,892	–	–	31.25%	1
2015 Q4	$121M	Hold	1,067,892	–	–	41.48%	1
2015 Q3	$126M	Hold	1,067,892	–	–	41.75%	1
2015 Q2	$82.7M	Hold	1,067,892	–	–	28.91%	1
2015 Q1	$61.8M	Hold	1,067,892	–	–	25.76%	2
2014 Q4	$34.4M	Hold	1,067,892	–	–	15.28%	3
2014 Q3	$26.1M	Hold	1,067,892	–	–	13.12%	3
2014 Q2	$18.9M	Hold	1,067,892	–	–	7.36%	4
2014 Q1	$21.4M	Sell	1,067,892 -3,000,000	-74%	-$58.2M	8.34%	5
2013 Q4	$68.3M	Sell	4,067,892 -1,553,531	-28%	-$21.5M	34.97%	2
2013 Q3	$59.7M	Hold	5,621,423	–	–	36.62%	2
2013 Q2	$31.4M	Buy	+5,621,423	New	+$34M	25.52%	3

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Rho Capital Partners's ANAC Position: Q2 2016 in Review

Rho Capital Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,067,892 shares — an estimated $57.1M sold.

Rho Capital Partners first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $126M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Rho Capital Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Rho Capital Partners sold 1,067,892 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $57.1M.
Rho Capital Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
Rho Capital Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $126M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Rho Capital Partners's 13F filing for Q2 2016, filed 13 Jul 2016.